• 文章类型: Journal Article
    这项研究的目的是比较Ramstedt幽门切开术治疗婴儿肥厚性幽门狭窄(IHPS)的脐带(UMB)和右上腹(RUQ)皮肤切口之间的手术参数和并发症发生率。PubMed,EMBASE,系统搜索了WebofScience和Scopus数据库。研究中的任何一个感兴趣的主要结果,即,手术时间,伤口感染率,据报道,粘膜穿孔率符合纳入标准.使用随机效应模型进行统计分析。使用纽卡斯尔-渥太华量表评估研究的方法学质量。15项研究包括2964名婴儿。与UMB组相比,RUQ组显示出显著较低的平均手术时间(p=0.0004),伤口感染率(p<0.0001)和粘膜穿孔率(p=0.02)。尽管UMB切口会产生几乎无法察觉的疤痕,这种方法导致明显更多的并发症.因此,在决定IHPS患者的手术方式时,必须权衡风险和收益,并与护理人员进行讨论.然而,由于15项研究中有9项的方法学质量较差,需要进行进一步的研究,以在两组之间进行最佳比较。
    The aim of this study was to compare the operative parameters and complication rates between the umbilical (UMB) and right upper quadrant (RUQ) skin incisions for Ramstedt\'s pyloromyotomy for the treatment of infantile hypertrophic pyloric stenosis (IHPS). PubMed, EMBASE, Web of Science and Scopus databases were systematically searched. The studies where any one of the main outcomes of interest, i.e., operative time, wound infection rate, mucosal perforation rate were reported were eligible for inclusion. The statistical analysis was performed using a random-effects model. The methodological quality of the studies was assessed utilizing the Newcastle-Ottawa Scale. Fifteen studies comprising 2964 infants were included. As compared to the UMB group, the RUQ group showed a significantly lower mean operative time (p = 0.0004), wound infection rate (p < 0.0001) and mucosal perforation rate (p = 0.02). Although UMB incision produces an almost undetectable scar, this approach results in significantly more complications. Therefore, the risks and benefits must be weighed and discussed with the caregivers in deciding the surgical approach in patients with IHPS. However, due to a poor methodological quality of nine out of fifteen studies, further studies need to be conducted for an optimal comparison between the two groups.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:心力衰竭,中风和死亡是与心房颤动(AF)相关的主要危险,常见的异常心律.胃肠道(GI)手术会使患者面临发生房颤的风险,尤其是腹部大手术后。尽管早期的研究表明术后房颤与较高的死亡率之间可能存在联系,这种相互作用的确切性质尚不确定。
    方法:为了研究房颤与胃肠道手术后死亡之间的关系,这项研究对随机对照研究或临床试验进行了全面的荟萃分析和系统评价.寻找相关的随机对照试验(RCT)需要在许多数据库中进行全面搜索。纳入标准的主要焦点是涉及胃肠道手术患者术后房颤和死亡率的研究。我们遵循PRISMA和Cochrane协作协议进行数据提取和质量评估,分别。
    结果:胃肠手术后,房颤组和非房颤组的死亡率差异无统计学意义,根据对现有试验的分析(p=0.97)。死亡率比值比(OR)为1.03(95%CI[0.24,4.41]),表明没有显著的相关性。然而,在整个试验中存在显著的异质性,这需要仔细解释。
    结论:尽管在我们的研究中房颤与胃肠道手术后死亡之间缺乏显著的联系,来自其他研究的矛盾数据凸显了这种关系的复杂性。差异可能来自患者人口统计学的变化,研究方法和程序问题。这些结果强调了进一步广泛和多样化研究的必要性,以充分阐明房颤在术后死亡率中与胃肠道手术相关的作用。理解这种相关性的微妙之处可能会增强未来患者的预后,并有助于基于证据的治疗决策。
    BACKGROUND: Heart failure, stroke and death are major dangers associated with atrial fibrillation (AF), a common abnormal heart rhythm. Having a gastrointestinal (GI) procedure puts patients at risk for developing AF, especially after large abdominal surgery. Although earlier research has shown a possible connection between postoperative AF and higher mortality, the exact nature of this interaction is yet uncertain.
    METHODS: To investigate the relationship between AF and death after GI procedures, this research carried out a thorough meta-analysis and systematic review of randomized controlled studies or clinical trials. Finding relevant randomized controlled trials (RCTs) required a comprehensive search across many databases. Studies involving GI surgery patients with postoperative AF and mortality outcomes were the main focus of the inclusion criteria. We followed PRISMA and Cochrane Collaboration protocols for data extraction and quality assessment, respectively.
    RESULTS: After GI surgery, there was no statistically significant difference in mortality between the AF and non-AF groups, according to an analysis of the available trials (p = 0.97). The mortality odds ratio (OR) was 1.03 (95% CI [0.24, 4.41]), suggesting that there was no significant correlation. Nevertheless, there was significant heterogeneity throughout the trials, which calls for careful interpretation.
    CONCLUSIONS: Despite the lack of a significant link between AF and death after GI surgery in our study, contradictory data from other research highlight the intricacy of this relationship. Discrepancies may arise from variations in patient demographics, research methodology and procedural problems. These results emphasize the necessity for additional extensive and varied studies to fully clarify the role of AF in postoperative mortality in relation to GI procedures. Comprehending the subtleties of this correlation might enhance future patient outcomes and contribute to evidence-based therapeutic decision making.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Systematic Review
    目的:这篇综述旨在评估机器人辅助腹腔镜手术(RALS)作为标准腹腔镜手术(SLS)治疗肠深浸润性子宫内膜异位症的替代方法的可行性。此外,它旨在为未来的研究设计提供指导,通过深入了解研究的现状,按照理想的框架。
    方法:进行了系统评价,以确定Medline中肠深部浸润性子宫内膜异位症的RALS的相关研究,Embase,Cochrane图书馆和PubMed数据库截至2023年8月,报告符合PRISMA指南。该研究已注册于PROSPERO注册:CRD42022308611结果:确定了11项主要研究,包括364名RALS患者和83名SLS患者,手术细节,提取手术和术后结果。在RALS组中,平均手术时间(235±112分钟)比标准腹腔镜组(171±76分钟)更长(p<0.01)。RALS组的患者住院时间较短(5.3±3.5天vs.7.3±4.1天)(p<0.01),与标准腹腔镜检查相比,术后并发症似乎更少。肠道DE中RALS的研究证据正处于理想的2B阶段。
    结论:RALS是一种安全可行的替代标准腹腔镜治疗肠型子宫内膜异位症的方法,一个较短的总长度,尽管较长的操作时间。推荐进一步的稳健随机试验来描述RALS的其他潜在优势。
    OBJECTIVE: This review aims to evaluate the feasibility of robot-assisted laparoscopic surgery (RALS) as an alternative to standard laparoscopic surgery (SLS) for the treatment of bowel deep-infiltrative endometriosis. Additionally, it aims to provide guidance for future study design, by gaining insight into the current state of research, in accordance with the IDEAL framework.
    METHODS: A systematic review was conducted to identify relevant studies on RALS for bowel deep infiltrating endometriosis in Medline, Embase, Cochrane Library and PubMed databases up to August 2023 and reported in keeping with PRISMA guidelines. The study was registered with PROSPERO Registration: CRD42022308611 RESULTS: Eleven primary studies were identified, encompassing 364 RALS patients and 83 SLS patients, from which surgical details, operative and postoperative outcomes were extracted. In the RALS group, mean operating time was longer (235 ± 112 min) than in the standard laparoscopy group (171 ± 76 min) (p < 0.01). Patients in the RALS group experienced a shorter hospital stay (5.3 ± 3.5 days vs. 7.3 ± 4.1 days) (p < 0.01), and appeared to have fewer postoperative complications compared to standard laparoscopy. Research evidence for RALS in bowel DE is at an IDEAL Stage 2B of development.
    CONCLUSIONS: RALS is a safe and feasible alternative to standard laparoscopy for bowel endometriosis treatment, with a shorter overall length of stay despite longer operating times. Further robust randomized trials recommended to delineate other potential advantages of RALS.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Systematic Review
    进行了系统评价和荟萃分析,以研究AirSeal无阀套管针吹气系统在机器人辅助肾部分切除术(RAPN)中的疗效。该研究比较了AirSeal吹气组(AIS)和常规吹气组(CIS)围手术期结局的差异。对PubMed等数据库的系统搜索,Embase,科克伦图书馆,我们进行了WebofScience,以确定在RAPN中AirSeal充气组(AIS)和常规充气组(CIS)之间报告围手术期结局的研究.研究方案在PROSPERO(CRD42024524335)注册。主要结果是比较两种方法之间皮下气肿(SCE)的发生率和术后疼痛评分。该综述包括四项研究,涉及379名患者,AIS组194例,CIS组185例。两组在所有结果中的基线特征相似。SCE在AIS组明显低于CIS组[(OR)0.30(0.16,0.54),p<0.001]。与CIS组相比,AIS组术后12小时疼痛评分也显着降低[(WMD)-0.93(-1.67,-1.09),p=0.014]。两组均显示住院时间显着减少[(WMD)-0.12(-0.84,0.60),p=0.746],热缺血时间[(WMD)4.72(-5.71,15.15),p=0.375],血红蛋白损失量[(WMD)-0.19(-0.53,0.15),p=0.284],气胸[(OR)0.13(0.02,1.10),p=0.062],纵隔气肿[(OR)0.55(0.20,1.46),p=0.230],和4小时疼痛评分[(WMD)-0.25(-1.16,0.65),p=0.584];没有观察到显著差异。与CIS组相比,AIS组的皮下气肿SCE发生率和12小时疼痛评分明显较低。在机器人辅助肾部分切除术中,AirSeal系统表现出与传统吹气系统相似的疗效和更高的安全性;然而,由于缺乏对该主题的随机研究,需要进一步的数据。
    A systematic review and meta-analysis were performed to investigate the efficacy of the AirSeal Valveless Trocar Needle Insufflation System in robot-assisted partial nephrectomy (RAPN). The study compared the differences in perioperative outcomes between the AirSeal insufflation group (AIS) and the conventional insufflation group (CIS). A systematic search of databases such as PubMed, Embase, Cochrane library, and Web of science was performed to identify studies reporting perioperative outcomes between the AirSeal insufflation group (AIS) and the conventional insufflation group (CIS) in RAPN. The study protocol is registered with PROSPERO (CRD42024524335). The primary outcome was to compare the incidence of subcutaneous emphysema (SCE) and postoperative pain scores between the two approaches. The review included four studies with 379 patients, 194 in the AIS group and 185 in the CIS group. Baseline characteristics of the two groups were similar in all outcomes. SCE was significantly lower in the AIS group than in the CIS group [(OR) 0.30 (0.16, 0.54), p < 0.001]. Postoperative 12-h pain scores were also significantly lower in the AIS group compared to the CIS group [(WMD) - 0.93 (- 1.67, - 1.09), p = 0.014]. Both groups showed a significant reduction in length of hospitalization [(WMD) - 0.12 (- 0.84, 0.60), p = 0.746], thermal ischemia time [(WMD) 4.72 (- 5.71, 15.15), p = 0.375], amount of lost hemoglobin [(WMD) - 0.19 (- 0.53, 0.15), p = 0.284], pneumothorax [(OR) 0.13 (0.02,1.10), p = 0.062], mediastinal emphysema [(OR) 0.55 (0.20, 1.46), p = 0.230], and 4-h pain score [(WMD) - 0.25 (- 1.16, 0.65), p = 0.584]; no significant differences were observed. The incidence of subcutaneous emphysema SCE and 12-h pain scores were significantly lower in the AIS group compared to the CIS group. The AirSeal system demonstrated similar efficacy and a higher safety profile than the conventional insufflation system in robotic-assisted partial nephrectomy; however, due to the lack of a randomized study on the topic, further data are needed.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    已提出短的牙科植入物作为骨再生程序的替代治疗选择,以修复被吸收的牙槽脊。本文的目的是系统地回顾随机对照试验(RCTs),比较短的植入物(≤6毫米)和较长的植入物(>6毫米)在萎缩牙槽脊的植入物存活率方面,种植体周围边缘骨丢失(MBL),种植体周围炎的患病率和技术并发症。直到2023年9月进行了彻底的电子搜索。RCTs在加载后至少1年随访,将具有粗糙表面的短植入物与系统和牙周健康的后颌骨中的较长植入物进行比较,考虑了部分缺牙的成年人。关于患者数量信息不完整的研究,随访或“短植入物”的定义被排除。用于随机试验的修订的Cochrane偏倚风险工具用于偏倚风险评估。对选定研究的固定效应荟萃分析用于比较结果变量。进行随机效应荟萃分析,在研究内比较的基础上。总的来说,选择16篇文章进行荟萃分析,并在317和388例患者中插入了408个短植入物和475个较长植入物,分别。与短植入物相比,原始或增强骨的较长植入物的存活率显着提高(95CI:2-5%,p<0.001)。标准长度的植入物显示增加,尽管MBL无统计学意义(95CI:-0.17-0.04,p>0.05),和种植体周围炎的患病率(95CI:0-5%,p>0.05)。在技术并发症方面,短植入物和长植入物之间没有观察到统计学上的显着差异(植入物水平95CI:-4-6%,p>0.05)。短植入物代表了后颌骨康复的一种有希望的替代治疗选择,以避免额外的骨增强程序。尽管如此,由于与更长的植入物相比,它们的存活率可能有限,因此应谨慎选择。这项研究的一个主要限制是纳入研究的样本量的可变性,患者简介,骨头的类型,加载协议,种植体周围炎的定义,在其他人中。这项研究没有获得外部资助。研究方案在PROSPERO(CRD42023485514)中注册。
    Short dental implants have been proposed as an alternative treatment option to bone regeneration procedures for the rehabilitation of resorbed alveolar ridges. The aim of this paper was to systematically review randomized controlled trials (RCTs) comparing short implants (≤6 mm) and longer implants (>6 mm) in atrophic alveolar ridges in terms of implant survival rates, peri-implant marginal bone loss (MBL), prevalence of peri-implantitis and technical complications. A thorough electronic search was performed until September 2023. RCTs with follow-up of at least 1-year post-loading comparing short implants with rough surfaces to longer implants in the posterior jaws of systemically and periodontally healthy, partially edentulous adults were considered. Studies with incomplete information on the number of patients, follow-up or definition of \"short implants\" were excluded. The revised Cochrane risk-of-bias tool for randomized trials was used for Risk of bias assessment. Fixed-effects meta-analysis of the selected studies was applied to compare the outcome variables. Random-effect meta-analysis was performed, on the basis of within-study comparisons. In total, 16 articles were selected for meta-analysis and incorporated 408 short implants and 475 longer implants inserted in 317 and 388 patients, respectively. The survival rates of longer implants in pristine or augmented bone were significantly increased compared to short implants (95%CI: 2-5%, p < 0.001). Standard-length implants displayed increased, although non-statistically significant MBL (95%CI: -0.17-0.04, p > 0.05), and prevalence of peri-implantitis (95%CI: 0-5%, p > 0.05). No statistically significant differences were observed between short and long implants in terms of technical complications (implant-level 95%CI: -4-6%, p > 0.05). Short implants represent a promising alternative treatment option for the rehabilitation of posterior jaws to avoid additional bone augmentation procedures. Nonetheless, they should be selected cautiously due to a potentially limited survival rate compared to longer implants. A major limitation of this study is the variability in the included studies regarding sample size, patient profile, type of bone, loading protocol, definition of peri-implantitis, among others. This study received no external funding. The study protocol was registered in PROSPERO (CRD42023485514).
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Systematic Review
    本系统综述和荟萃分析研究了术中目标导向治疗(GDT)与常规液体治疗相比对肾移植受者术后结局的影响,解决当前文献中的这一差距。
    在PubMed中对年龄≥18岁的患者进行了截至2022年6月的单器官原发性肾移植,Embase,进行了Scopus和CINAHLPlus。检查的主要结果是术后肾功能。评估的次要结果是移植物再灌注时的平均动脉压,术中液体量和其他术后并发症。使用I²检验测试异质性。研究方案在PROSPERO上注册。
    共确定了2459项研究。纳入了607例患者的7项合格研究。亚组评估显示GDT的潜在肾脏保护益处,接受尸体移植的患者在术后第1天和第3天显示血清肌酐较低,并且使用动脉波形分析设备监测的患者术后血液透析发生率较低。总体分析发现,GDT导致组织水肿(风险比[RR]0.34,95%CI0.15-0.78,P=0.01)和呼吸系统并发症(RR0.39,95%CI0.17-0.90,P=0.03)的发生率较低。然而,考虑到非随机研究,数据质量被认为较低,在定义结果衡量标准时存在异质性和不一致性。
    虽然没有明确的结论可以确定当前的限制,这篇综述重点介绍了在肾移植受者中使用GDT的潜在益处.它提示需要进一步的标准化研究来解决本综述中讨论的局限性。
    UNASSIGNED: This systematic review and meta-analysis investigated the impact of intraoperative goal-directed therapy (GDT) compared with conventional fluid therapy on postoperative outcomes in renal transplantation recipients, addressing this gap in current literature.
    UNASSIGNED: A systematic search of patients aged ≥18 years who have undergone single-organ primary renal transplantations up to June 2022 in PubMed, Embase, Scopus and CINAHL Plus was performed. Primary outcome examined was postoperative renal function. Secondary outcomes assessed were mean arterial pressure at graft reperfusion, intraoperative fluid volume and other postoperative complications. Heterogeneity was tested using I² test. The study protocol was registered on PROSPERO.
    UNASSIGNED: A total of 2459 studies were identified. Seven eligible studies on 607 patients were included. Subgroup assessments revealed potential renal protective benefits of GDT, with patients receiving cadaveric grafts showing lower serum creatinine on postoperative days 1 and 3, and patients monitored with arterial waveform analysis devices experiencing lower incidences of postoperative haemodialysis. Overall analysis found GDT resulted in lower incidence of tissue oedema (risk ratio [RR] 0.34, 95% CI 0.15-0.78, P=0.01) and respiratory complications (RR 0.39, 95% CI 0.17-0.90, P=0.03). However, quality of data was deemed low given inclusion of non-randomised studies, presence of heterogeneities and inconsistencies in defining outcomes measures.
    UNASSIGNED: While no definitive conclusions can be ascertained given current limitations, this review highlights potential benefits of using GDT in renal transplantation recipients. It prompts the need for further standardised studies to address limitations discussed in this review.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • DOI:
    文章类型: Journal Article
    术后早期疼痛控制对于促进骨科手术后的快速恢复至关重要。尽管髋臼周围截骨术(PAO)是关节炎前髋关节发育不良的黄金标准治疗,评估术后早期疼痛管理策略疗效的证据有限.最近的文献集中于非阿片样物质补充治疗,例如神经阻滞或局部伤口浸润。本系统评价的目的是评估这些干预措施对减轻疼痛的疗效。促进动员,减少PAO手术后的住院时间。
    在PRISMA的指导下,从包括PubMed,OVIDMedline,Embase,Scopus,Cochrane临床试验中央注册中心,和clinicaltrials.gov从创建日期到23年12月21日。这些研究根据预定的纳入和排除标准进行筛选。
    本次分析共纳入了来自独立机构的6项研究。三个被调查的神经阻滞(髂筋膜,包膜,腹横肌),其中一人调查了罗哌卡因局部伤口浸润,一个人调查了大剂量地塞米松,与POD2相比,最后一次研究在术后(POD)1去除硬膜外导管。从这些研究中衡量的结果是异质的。总的来说,神经阻滞减少了阿片类药物的使用,疼痛,和住院时间。局部伤口浸润减轻了POD3和4的疼痛。与POD2相比,在POD1上去除硬膜外导管可减少疼痛和住院时间。大剂量地塞米松的使用减少了POD1的阿片类药物的使用,否则,疼痛没有区别。
    总之,PAO手术的围手术期补充疼痛管理策略可以减轻疼痛,阿片类药物的使用,以及住院时间,尽管很少有研究评估这些干预措施。手术后限制阿片类药物的使用可以减少已知的药物负面后果,并促进快速康复。需要进行临床试验,以评估PAO手术后补充疼痛管理策略的有效性。证据等级:II。
    UNASSIGNED: Early post-operative pain control is essential to facilitate rapid recovery after orthopaedic surgery. Despite periacetabular osteotomy (PAO) being the gold standard treatment of prearthritic hip dysplasia, there is limited evidence assessing efficacy of early post-operative pain management strategies. Recent literature has focused on non-opioid supplemental treatments such as nerve blocks or local wound infiltration. The purpose of this systematic review was to assess efficacy of these interventions to reduce pain, facilitate mobilization, reduce length of stay after PAO surgery.
    UNASSIGNED: A systematic review was created under the guidance of PRISMA from databases that included PubMed, OVID Medline, Embase, SCOPUS, Cochrane Central Register of Clinical Trials, and clinicaltrials.gov from their creation dates to 12/21/23. These studies were screen based on predetermined inclusion and exclusion criteria.
    UNASSIGNED: A total of six studies were included in this analysis from independent institutions. Three investigated nerve blocks (fascia iliaca, pericapsular, transversus abdominis), one investigated local wound infiltration with ropivacaine, one investigated high-dose dexamethasone, and the last investigated removal of the epidural catheter on postoperative (POD) 1 compared to POD 2. There were heterogeneous outcomes that were measured from these studies. In general, nerve blocks decreased opioid use, pain, and length of hospital stay. The local wound infiltration decreased pain on POD 3 and 4. Removing the epidural catheter on POD1 compared to POD 2 decreased pain and length of stay. High-dose dexamethasone use decreased opioid use on POD 1, otherwise, there was no difference in pain.
    UNASSIGNED: In summary, supplemental pain management strategies peri-operatively for PAO surgery can decrease pain, opioid use, and length of hospital stay, though there are few studies assessing these interventions. Limiting opioid use after surgery reduces known negative consequences of the medication and facilitates rapid recovery. Clinical trials are needed that assess efficacy of supplemental pain management strategies after PAO surgery. Level of Evidence: II.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:克罗恩病(CD)是一种慢性疾病,其特征是手术后复发率高,严重影响患者的生活质量。许多研究探讨了CD术后复发的危险因素,缺乏将内镜术后复发(ePOR)作为临床结局的荟萃分析.因此,本文旨在通过系统评价和荟萃分析来确定CD患者ePOR的危险因素。
    方法:PubMed,Embase,科克伦图书馆,从开始到2023年10月17日,搜索了WebofScience数据库的相关文献。两名研究者独立筛选文献并提取信息。使用Stata18.0进行数据分析。
    结果:包括23篇论文,5个病例对照研究和18个队列研究。美国国立卫生研究院质量评估工具将17项研究评为良好,将6项研究评为公平。23项研究的样本量从40到346不等,ePOR患者的数量从23到169不等。多变量荟萃分析结果显示,吸烟[OR=2.06,95%CI(1.65,2.57),P=0.0001],既往回肠结肠切除术[OR=1.71,95%CI(1.23,2.38),P=0.002],回肠结肠切除术时的疾病定位[OR=2.68,95%CI(1.38,5.22),P=0.004],肛周疾病[OR=1.47,95%CI(1.07,2.03),P=0.017],吻合口散见性溃疡[OR=3.39,95%CI(1.83,6.28),P=0.001是CD患者ePOR的危险因素。术后预防性用药[OR=0.53,95%CI(0.38,0.75),P=0.0001]是CD患者ePOR的保护因素。
    结论:本系统评价确定了CD患者ePOR的多种因素,也是一个保护因素。然而,包含的文章数量有限。需要更多高质量的临床研究来进一步验证结论。
    背景:本研究已在国际前瞻性系统审查注册(PROSPERO)(CRD42023483671)中注册。
    BACKGROUND: Crohn\'s disease (CD) is a chronic condition characterized by a high recurrence rate after surgery, which seriously affects the quality of life of patients. Many studies have explored the risk factors for the recurrence of CD after surgery, there is a lack of meta-analysis focusing on endoscopic postoperative recurrence (ePOR) as a clinical outcome. Therefore, this paper aims to identify the risk factors for ePOR in CD patients through systematic review and meta-analysis.
    METHODS: PubMed, Embase, Cochrane Library, and Web of Science databases were searched for related literature from inception to 17th October 2023. Two researchers independently screened the literature and extracted information. Data analysis was performed using Stata18.0.
    RESULTS: Twenty-three papers were included, with 5 case-control studies and 18 cohort studies. The National Institutes of Health quality assessment tool rated 17 studies as good and 6 studies as fair. The sample size of the 23 studies ranged from 40 to 346, and the number of patients with ePOR ranged from 23 to 169. The results of multivariate meta-analysis showed that smoking [OR = 2.06, 95% CI (1.65, 2.57), P = 0.0001], previous ileocolonic resection [OR = 1.71, 95% CI (1.23, 2.38), P = 0.002], disease localization at ileocolic resection [OR = 2.68, 95% CI (1.38, 5.22), P = 0.004], perianal disease [OR = 1.47, 95% CI (1.07, 2.03), P = 0.017], and anastomotic scattered ulcer [OR = 3.39, 95% CI (1.83, 6.28), P = 0.001] were risk factors for ePOR in CD patients. Postoperative prophylactic medication [OR = 0.53, 95% CI (0.38,0.75), P = 0.0001] was a protective factor for ePOR in CD patients.
    CONCLUSIONS: This systematic review identified multiple factors for ePOR in CD patients, as well as a protective factor. However, the number of articles included was limited. More high-quality clinical studies are required to further validate the conclusions.
    BACKGROUND: This study was registered in the International Prospective Register of Systematic Reviews (PROSPERO) (CRD42023483671).
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:法洛四联症(TOF)是全球最常见的紫红色先天性心脏病(CHD)。它占乌干达冠心病病例的7%,长期不手术导致致命的结果。在乌干达等发展中国家,由于资源有限,手术经常被推迟。
    目的:本研究旨在确定在乌干达心脏研究所(UHI)接受原发性心内修复的TOF患者的早期手术结果,并确定相关因素。
    方法:本回顾性图表评估了2012年2月至2022年10月在UHI治疗的原发性TOF修复患者的结局。从手术直到手术后30天评估患者结果。
    结果:在UHI接受原发性TOF修复的104例患者中,88例患者(84.6%)的记录可供查阅.男性占48.9%(n=43)。手术时的中位年龄为4岁(四分位距为2.5-8.0岁),从9个月到16年不等。5/88(5.7%)存在遗传综合征。其中包括2例21三体,2例Noonan\s,1与22q11.2缺失综合征。患者术后早期结果包括:35/88的残余室间隔缺损(39.8%),33/88(37.5%)右心室功能障碍,27/88(30.7%)的残余肺返流,残余右室流出道梗阻27/88(30.0%),24/88胸腔积液(27.3%),24/88的心律失常(27.3%),术后感染23/88(26.1%),左心室收缩功能障碍9/88(10.2%)。在一岁后接受手术的儿童中,8%(7名儿童)在前30天内死亡。死亡率和术后通气时间之间存在相关性,体外循环(CPB)时间,主动脉交叉钳夹时间,术前氧饱和度,RV和LV功能障碍和手术团队。
    结论:手术后最常见的结果是残余室间隔缺损和右心室衰竭。在我们的研究中,TOF修复后30天死亡率为8%.死亡患者术前氧气水平较低,更长的CPB和交叉夹紧时间,术后通气时间延长,RV/LV功能障碍,更有可能由当地团队操作。
    BACKGROUND: Tetralogy of Fallot (TOF) is the most common form of cyanotic congenital heart disease (CHD) worldwide. It accounts for 7% of CHD cases in Uganda and leads to fatal outcomes in the long term without surgery. Surgery is often delayed in developing countries like Uganda due to limited resources.
    OBJECTIVE: This study aimed to determine the early surgical outcomes of patients with TOF who underwent primary intracardiac repair at the Uganda Heart Institute (UHI) and to identify factors associated.
    METHODS: This retrospective chart review evaluated outcomes of primary TOF repair patients at UHI from February 2012 to October 2022. Patient outcomes were assessed from surgery until 30 days post-operation.
    RESULTS: Out of the 104 patients who underwent primary TOF repair at UHI, records of 88 patients (84.6%) were available for review. Males accounted for 48.9% (n = 43). The median age at the time of operation was 4 years (with an interquartile range of 2.5-8.0 years), ranging from 9 months to 16 years. Genetic syndromes were present in 5/88 (5.7%). These included 2 patients with trisomy 21, 2 with Noonan\'s, and 1 with 22q11.2 deletion syndrome. Early postoperative outcomes for patients included: residual ventricular septal defects in 35/88 (39.8%), right ventricular dysfunction in 33/88 (37.5%), residual pulmonary regurgitation in 27/88 (30.7%), residual right ventricular outflow tract obstruction in 27/88 (30.0%), pleural effusion in 24/88 (27.3%), arrhythmias in 24/88(27.3%), post-operative infections in 23/88(26.1%) and left ventricular systolic dysfunction in 9/88 (10.2%). Out of the children who underwent surgery after one year of age, 8% (7 children) died within the first 30 days. There was a correlation between mortality and post-operative ventilation time, cardiopulmonary bypass (CPB) time, aortic cross-clamp time, preoperative oxygen saturations, RV and LV dysfunction and the operating team.
    CONCLUSIONS: The most frequent outcomes after surgery were residual ventricular septal defects and right ventricular failure. In our study, the 30-day mortality rate following TOF repair was 8%. Deceased patients had lower pre-operative oxygen levels, longer CPB and cross-clamp times, longer post-operative ventilation, RV/LV dysfunction, and were more likely operated by the local team.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    尽管缺乏机器人腹侧疝修补术(RVHR)在肥胖患者中的证据,机器人平台在疝气手术中的使用越来越频繁。肥胖对RVHR结果的影响尚未得到彻底研究。肥胖被认为是复发性腹侧疝和术后并发症发展的主要危险因素;然而,我们假设接受机器人修复的患者将有相似的并发症特征,尽管他们的体重指数(BMI).我们使用来自腹部核心健康质量协作登记的数据,对2013年至2023年期间接受RVHR的18-90岁患者进行了回顾性分析。术前,术中,比较非肥胖和肥胖组的术后特征,使用单变量和逻辑回归分析来比较短期结果。登记处确定了9742名患者;3666名非肥胖;6076名被归类为肥胖(BMI>30kg/m2)。肥胖患者发生手术部位的几率增加,主要是血清肿形成;然而,肥胖不是RVHR术后需要手术干预的并发症的重要因素.相比之下,所有患者手术后的疝气特异性生活质量评分显著改善,与肥胖患者相比,基线有更多的改善。肥胖确实以BMI依赖的方式增加RVHR后某些并发症的风险;然而,BMI并未显著增加需要程序性干预的几率.肥胖患者的生活质量有显著改善,在这一人群中,应仔细考虑RVHR。
    Despite the paucity of evidence on robotic ventral hernia repair (RVHR) in patients with obesity, the robotic platform is being used more frequently in hernia surgery. The impact of obesity on RVHR outcomes has not been thoroughly studied. Obesity is considered a major risk factor for the development of recurrent ventral hernias and postoperative complications; however, we hypothesize that patients undergoing robotic repairs will have similar complication profiles despite their body mass index (BMI). We performed a retrospective analysis of patients aged 18-90 years who underwent RVHR between 2013 and 2023 using data from the Abdominal Core Health Quality Collaborative registry. Preoperative, intraoperative, and postoperative characteristics were compared in non-obese and obese groups, determined using a univariate and logistic regression analysis to compare short-term outcomes. The registry identified 9742 patients; 3666 were non-obese; 6076 were classified as obese (BMI > 30 kg/m2). There was an increased odds of surgical site occurrence in patients with obesity, mostly seroma formation; however, obesity was not a significant factor for a complication requiring a procedural intervention after RVHR. In contrast, the hernia-specific quality-of-life scores significantly improved following surgery for all patients, with those with obesity having more substantial improvement from baseline. Obesity does increase the risk of certain complications following RVHR in a BMI-dependent fashion; however, the odds of requiring a procedural intervention are not significantly increased by BMI. Patients with obesity have a significant improvement in their quality of life, and RVHR should be carefully considered in this population.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号